Q2 2026 Holdings
Filed 2026-08-14 | 33 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $600.4M | 22,970,388 | 29.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $531.9M | 7,880,094 | 25.9% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $155.5M | 4,824,469 | 7.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $106.2M | 1,494,300 | 5.2% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $78.6M | 2,171,938 | 3.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $75.8M | 1,389,276 | 3.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $72.9M | 6,728,116 | 3.5% |
| First Tracks Biotherapeutics(TRAX) | ORD SHS ADDED | 337185102 | $63.9M | 3,174,519 | 3.1% |
| Lakefront Biotherapeutics NV(GLPG) | SPON ADR | 36315X101 | $50.0M | 1,667,119 | 2.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $40.0M | 1,271,342 | 1.9% |
| CG Oncology Inc(CGON)Call | COM | 156944100 | $39.9M | 561,500 | 1.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $24.0M | 735,000 | 1.2% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $24.0M | 6,549,866 | 1.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $23.1M | 800,000 | 1.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $21.5M | 2,823,126 | 1.0% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $21.4M | 388,500 | 1.0% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $20.0M | 789,500 | 1.0% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $17.8M | 1,552,000 | 0.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $13.1M | 697,948 | 0.6% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $11.8M | 1,666,667 | 0.6% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK ADDED | 67613T104 | $10.4M | 555,555 | 0.5% |
| Eikon Therapeutics Inc(EIKN) | COM | 282564103 | $9.6M | 732,606 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $8.1M | 235,000 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $7.0M | 1,179,715 | 0.3% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $6.8M | 625,000 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $6.6M | 270,000 | 0.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.0M | 330,000 | 0.3% |
| Eloxx Pharmaceuticals Inc(ELOX) | COM NEW ADDED | 29014R301 | $5.6M | 400,000 | 0.3% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $2.3M | 396,194 | 0.1% |
| Helix Acquisition Corp III USD | CL A ORD SHS | G4444S107 | $2.1M | 200,000 | 0.1% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $317.7K | 1,000,000 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $115.3K | 4,444 | 0.0% |
| Aardvark Therapeutics Inc(AARD)Call | COM | 002942100 | $84.7K | 14,700 | 0.0% |